Deletion of haematopoietic Dectin-2 or CARD9 does not protect from atherosclerosis development under hyperglycaemic conditions

Kathrin Thiem*, Geerte Hoeke, Enchen Zhou, Anneke Hijmans, Tom Houben, Margien G. Boels, Isabel M. Mol, Esther Lutgens, Ronit Shiri-Sverdlov, Johan Bussink, Thirumala D. Kanneganti, Mariette R. Boon, Rinke Stienstra, Cees J. Tack, Patrick C. N. Rensen, Mihai G. Netea, Jimmy F. P. Berbee, Janna A. van Diepen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1-12
Number of pages12
JournalDiabetes & Vascular Disease Research
Volume17
Issue number1
Early online date23 Dec 2019
DOIs
Publication statusPublished - Jan 2020

Keywords

  • Atherosclerosis
  • CARD9
  • C-type lectin receptors
  • Dectin-2
  • hyperglycaemia
  • inflammation
  • monocytes
  • macrophages
  • CARDIOVASCULAR-DISEASE
  • LECTIN RECEPTORS
  • EXPRESSION
  • INFLAMMATION
  • CHOLESTEROL
  • LIGANDS
  • RISK
  • RAGE
  • MICE
  • TLR

Cite this